NASDAQ:SABS | Operating Income | SAB Biotherapeutics, Inc.

Complete source-backed operating income history.

Available history
2020-12-31 to 2026-06-30
Data captured

Historical Operating Income

DateOperating Income
2026-06-30-$23.38M
2026-03-31-$20M
2025-12-31-$15.77M
2025-09-30-$12.68M
2025-06-30-$9.73M
2025-03-31-$10.77M
2024-12-31-$10.01M
2024-09-30-$11.31M
2024-06-30-$10.2M
2024-03-31-$11.39M
2023-12-31-$18.87M
2023-09-30-$5.32M
2023-06-30-$6.48M
2023-03-31-$7.4M
2022-12-31-$7.86M
2022-09-30-$7.81M
2022-06-30-$6.54M
2022-03-31-$6.71M
2021-12-31-$7.34M
2021-09-30-$3.99M
2021-06-30-$2.87M
2021-03-31$813,924.00

Annual Operating Income

DateOperating Income
2025-12-31-$48.95M
2024-12-31-$42.91M
2023-12-31-$38.08M
2022-12-31-$28.92M
2021-12-31-$13.39M
2020-12-31$20.56M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.